Intravitreal

Dose response demonstrated in favor of highest tested dose of 3E10 vg/eye, including 100% reduction in supplemental…
Read More...

Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of the PRISM clinical trial…
Read More...

New clinical site added and early safety signals observed in trial for treatment of ocular disease caused by oxidative…
Read More...

<!-- Name:DistributionId Value:8830389 --> <!--…
Read More...

- Data demonstrating that Ixo-vec was generally well tolerated and that a single intravitreal (IVT) injection can lead…
Read More...

At the American Academy of…
Read More...

NEW YORK CITY -- Postoperative intravitreal methotrexate for…
Read More...

SAN ANTONIO -- Face masks became seeded "almost…
Read More...

-- Results featured in a presentation today at the Retina Society’s 54th Annual Scientific Meeting -- -- Robust…
Read More...